Mereo BioPharma Group plc Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Mereo BioPharma Group plc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q3 2025.
  • Mereo BioPharma Group plc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2025 was $378K, a 58.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)

Mereo BioPharma Group plc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $378K -$531K -58.4% Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $522K -$463K -47% Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $622K -$487K -43.9% Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $727K -$518K -41.6% Dec 31, 2024 10-Q 2025-11-10
Q3 2024 $909K Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $985K Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.11M Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.25M -$420K -25.2% Dec 31, 2023 10-K 2025-03-26
Q4 2022 $1.67M Dec 31, 2022 10-K 2024-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.